Hsp90 inhibitors in oncology: ready for prime time?
Abstract
-
Keywords
Hsp90; heat shock protein 90; targeted therapies; lung cancer; breast cancer; advanced malignancies
DOI: http://dx.doi.org/10.3747/co.21.2163
Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)